Medical Research Finder

Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Small-cell-lung-cancer (SCLC)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Register for a free trial

Navigation

Contents

Patients with small-cell lung cancer (SCLC) are at high risk for intracranial metastatic disease (IMD).
Gaebe et al. 2022 The Lancet Oncology 23(7): 931-939

Lung cancer is the leading cause of cancer deaths worldwide, of which small-cell lung cancer (SCLC) is a highly lethal type because most patients present with incurable, extensive-stage SCLC (ES-SCLC), associated with poor prognosis and treatment options are scarce
Chen et al. 2021j Immunotherapy 13: 1165-1177
Wang et al. 2022d The Lancet Oncology 23(6): 739-747

Small-cell lung cancer (SCLC) is a deadly tumor accounting for approximately 15% of lung cancers and is pa…

References (Sources)

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Wang et al. 2022d The Lancet Oncology 23(6): 739-747
Chemotherapy or chemo-immunotherapy as ﬁrst-line treatment for extensive-stage small-cell lung cancer: a meta-analysis
Chen et al. 2021j Immunotherapy 13: 1165-1177
Current and future therapeutic approaches for the treatment of small cell lung cancer
Rossi et al. 2018a Expert Review of Anticancer Therapy 18: 473-486
Review
Emerging drugs for small cell lung cancer an update
Metro et al., 2012
Review
Progress in Small-Cell Lung Cancer: The Lowest Common Denominator
Gandara & Lara, 2008
Small-cell lung cancer: what we know, what we need to know and the path forward
Gazdar et al. 2017
Review
Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis
Gaebe et al. 2022 The Lancet Oncology 23(7): 931-939

AI Chat

7/1/2026

Chat with our artificial intelligence:

Links

Small-cell carcinoma - Wikipedia